Lymphoma Clinical Trials in Baltimore

Showing 341-343 of 343 trials

A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.

NCT00333008

The purpose of this study is to evaluate the feasibility and tolerability of delivering a full dose, on time schedule of dose-dense CDOP-R (cyclophosphamide, doxil, vincristine, prednisone, and rituximab) in NHL.

Diffuse Large B Cell LymphomaLymphoma, Non-Hodgkin

The Alvin and Lois Lapidus Cancer Institute27 participantsStarted May 2006

Baltimore, Maryland, United States • Randallstown, Maryland, United States

UNKNOWNPHASE1181 miles

Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

NCT00090727

The purposes of this study are to determine: * the largest dose of AQ4N that can be safely given once a week for three weeks out of a 4 week cycle * the side effects of AQ4N when given on the above schedule * how much AQ4N is in the blood and urine at specific times after administration and how the body get rids of AQ4N * if AQ4N helps treat cancer

Solid MalignanciesNon-Hodgkin's Lymphoma

Novacea45 participantsStarted Aug 2004

The Bronx, New York, United States • San Antonio, Texas, United States

COMPLETEDPHASE2186 miles

Elsamitrucin (SPI 28090) for Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00090090

To determine the safety and efficacy of elsamitrucin in patients with relapsed or refractory non-Hodgkin's lymphoma (NHL). To determine if elsamitrucin is efficacious in a particular pathologic NHL subtype(s).

Mantle Cell LymphomaChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Spectrum Pharmaceuticals, Inc114 participantsStarted Apr 2004

Berkeley, California, United States • Burbank, California, United States • Los Angeles, California, United States +4 more locations

A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.

Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Elsamitrucin (SPI 28090) for Relapsed or Refractory Non-Hodgkin's Lymphoma

Lymphoma Trials in Other Cities

Other Conditions in Baltimore